Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Oaktree Acquisition stocks are traded under the ticker 4FE.STU.
When is the next Oaktree Acquisition earnings date?▼
Oaktree Acquisition is going to release the next earnings report on November 9, 2026.
What were Oaktree Acquisition earnings last quarter?▼
4FE.STU earnings for the last quarter are -0.32 EUR per share, whereas the estimation was -0.04 EUR resulting in a -643.15% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Oaktree Acquisition revenue for the last year?▼
Oaktree Acquisition revenue for the last year amounts to 2.04B EUR.
What is Oaktree Acquisition net income for the last year?▼
4FE.STU net income for the last year is 112.8M EUR.
How many employees does Oaktree Acquisition have?▼
As of November 7, 2026, the company has 2,442 employees.
In which sector is Oaktree Acquisition located?▼
Oaktree Acquisition operates in the Health & Wellness sector.
When did Oaktree Acquisition complete a stock split?▼
Oaktree Acquisition has not had any recent stock splits.
Where is Oaktree Acquisition headquartered?▼
Oaktree Acquisition is headquartered in SAN FRANCISCO, United States.